S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 30 of 30

Issue Date	Title / Author(s) / Citation	File
2004-12	A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma Sun, Jong-Mu; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue; Choe, Kuk Jin; Kim, Noe Kyeong Cancer, Vol.101 No.11, pp.2516-2522	DOI
2007-04	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy Lee, Kyung-Hun; Im, Seock-Ah; Oh, Do-Youn; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 63	view file DOI
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	view file DOI
2008-10	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You BMC Cancer, Vol.8, p. 307	view file DOI
2009-05	Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer Jung, So-Youn; Han, Wonshik; Lee, Jong Won; Ko, Eunyoung; Kim, Eunkyu; Yu, Jong-Han; Moon, Hyeong-Gon; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Hwang, Ki-Tae; Kim, Sung-Won; Noh, Dong-Young Annals of Surgical Oncology, Vol.16 No.5, pp.1112-1121	DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2009-10	Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy Han, Hye-Suk; Kim, Jin-Soo; Park, Jin Hyun; Jeon, Yoon Kyung; Lee, Keun-Wook; Oh, Do-Youn; Kim, Jee Hyun; Park, So Yeon; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Bang, Yung-Jue Journal of Korean Medical Science, Vol.24 No.5, pp.910-917	view file DOI
2010-02	Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity Lim, Kyu-Hyoung; Oh, Do-Youn; Chie, Eui Kyu; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Ha, Sung Whan; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.40 No.2, pp.112-118	DOI
2010-02	Prognostic Value of p53 and bcl-2 Expression in Patients Treated with Breast Conservative Therapy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Journal of Korean Medical Science, Vol.25 No.2, pp.235-239	view file DOI
2010-06	Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy Yhim, Ho-Young; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Kim, Young Tae; Noh, Dong-Young; Chie, Eui Kyu; Ha, Sung Whan; Park, In Ae; Bang, Yung-Jue Cancer, Vol.116 No.12, pp.2890-2901	DOI
2010-10	Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less Kwon, Ji Hyun; Kim, Yu Jung; Lee, Keun-Wook; Oh, Do-Youn; Park, So Yeon; Kim, Jee Hyun; Chie, Eui Kyu; Kim, Sung-Won; Im, Seock-Ah; Kim, In-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Ha, Sung Whan BMC Cancer, Vol.10, p. 557	view file DOI
2011-03	Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis Keam, Bhumsuk; Im, Seock-Ah; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Breast Cancer Research, Vol.13 No.2, p. R22	view file DOI
2011-05	Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeon, Yoon Kyung; Park, In Ae; Han, Wonshick; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.5, pp.593-599	DOI
2011-09	Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Park, Sohee; Nam, Byung-Ho; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Cancer Research and Clinical Oncology, Vol.137 No.9, pp.1301-1308	DOI
2011-10	Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue BMC Cancer, Vol.11, p. 452	DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2012-08	ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue Oncology, Vol.83 No.4, pp.218-227	DOI
2012-12	Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data Lee, Kytmg-Hun; Keam, Bhumsuk; Im, Seock-Ah; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Breast Cancer, Vol.15 No.4, pp.427-433	view file DOI
2013-04	Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue Breast Cancer, Vol.20 No.2, pp.167-173	DOI
2013-07	HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.1, pp.109-115	DOI
2013-07	Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer Keam, Bhumsuk; Im, Seock-Ah; Lim, Yoojoo; Han, Sae-Won; Moon, Hyeong-Gon; Oh, Do-Youn; Cho, Nariya; Lee, Se-Hoon; Han, Wonshik; Moon, Woo Kyung; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young Annals of Surgical Oncology, Vol.20 No.7, pp.2242-2249	DOI
2013-11	Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.5, pp.1023-1029	DOI
2013-12	Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response Lee, Ho-Chang; Ko, Hyoungsuk; Seol, Hyesil; Noh, Dong-Young; Han, Wonshik; Kim, Tae-You; Im, Seock-Ah; Park, In Ae Journal of Breast Cancer, Vol.16 No.4, pp.395-403	DOI
2014-08	Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer Cha, Yongjun; Han, Sae-Won; Seol, Hyesil; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, In Ae; Han, Wonshik; Noh, Dong-Young; Kim, Tae-You Anticancer Research, Vol.34 No.8, pp.4275-4280
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-04	Nomogram for predicting breast conservation after neoadjuvant chemotherapy Kim, Min Kyoon; Han, Wonshik; Moon, Hyeong-Gon; Ahn, Soo Kyung; Kim, Jisun; Lee, Jun Woo; Kim, Ju-Yeon; Kim, Taeryung; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young Cancer Research and Treatment, Vol.47 No.2, pp.197-207	DOI
2015-09	Radioactive iodine therapy did not significantly increase the incidence and recurrence of subsequent breast cancer Ahn, Hwa Young; Min, Hye Sook; Yeo, Yohwan; Ma, Seung Hyun; Hwang, Yunji; An, Jee Hyun; Choi, Hoon Sung; Keam, Bhumsuk; Im, Seock-Ah; Park, Do Joon; Park, In Ae; Noh, Dong-Young; Youn, Yeo-Kyu; Chung, June-Key; Cho, Bo Youn; Park, Sue Kyung; Park, Young Joo Journal of Clinical Endocrinology and Metabolism, Vol.100 No.9, pp.3486-3493	DOI
2015-12	A Possible Association Between Thyroid Cancer and Breast Cancer An, Jee Hyun; Hwangbo, Yul; Ahn, Hwa Young; Keam, Bhumsuk; Lee, Kyu Eun; Han, Wonshik; Park, Do Joon; Park, In Ae; Noh, Dong-Young; Youn, Yeo-Kyu; Cho, Bo Youn; Im, Seock-Ah; Park, Young Joo Thyroid, Vol.25 No.12, pp.1330-1338	DOI
2016-03	Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy Kim, Hyori; Youk, Jeonghwan; Yang, Yaewon; Kim, Tae-Yong; Min, Ahrum; Ham, Hye-Seon; Cho, Seongcheol; Lee, Kyung-Hun; Keam, Bhumsuk; Han, Sae-Won; Oh, Do-Youn; Ryu, Han Suk; Han, Wonshik; Park, In Ae; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Journal of Cancer Research and Clinical Oncology, Vol.142 No.3, pp.707-714	DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI